Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
德康醫療
DXCM
5
Workday
WDAY
(FY)2024/12/31 | (Q4)2024/12/31 | (Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | 6.21%5.14億 | 8.76%1.35億 | 2.46%1.27億 | 6.74%1.25億 | 6.92%1.27億 | 2.32%4.84億 | 5.96%1.24億 | 3.63%1.24億 | 1.69%1.17億 | -1.91%1.19億 |
淨利息收入 | 7.61%4.54億 | 8.98%1.18億 | 6.02%1.15億 | 8.02%1.1億 | 7.42%1.11億 | 1.35%4.22億 | 5.95%1.09億 | 3.76%1.08億 | -0.34%1.02億 | -3.77%1.04億 |
-利息收入總計 | 8.00%5.29億 | 9.55%1.38億 | 7.13%1.34億 | 8.31%1.28億 | 6.99%1.29億 | 8.62%4.9億 | 7.46%1.26億 | 7.76%1.25億 | 7.57%1.18億 | 11.87%1.2億 |
-利息費用總計 | 10.48%7,453萬 | 13.11%1,980.5萬 | 14.21%1,935.6萬 | 10.11%1,786.5萬 | 4.30%1,750.4萬 | 97.13%6,746.3萬 | 17.87%1,751萬 | 42.86%1,694.7萬 | 114.49%1,622.4萬 | 28,544.07%1,678.2萬 |
非利息收入總計 | -3.39%5,960.9萬 | 7.22%1,658.6萬 | -21.78%1,240.6萬 | -1.78%1,512.7萬 | 3.47%1,549萬 | 9.53%6,170.1萬 | 6.07%1,546.9萬 | 2.77%1,586萬 | 17.56%1,540.1萬 | 13.27%1,497.1萬 |
-已賺總保險費總額 | -8.61%4,069.5萬 | 7.35%1,179.2萬 | -34.79%742.2萬 | -6.21%1,050.7萬 | 0.14%1,097.4萬 | 2.36%4,452.9萬 | 2.18%1,098.5萬 | -5.05%1,138.2萬 | 9.62%1,120.3萬 | 3.94%1,095.9萬 |
-其他非利息收入 | 10.14%1,891.4萬 | 6.91%479.4萬 | 11.30%498.4萬 | 10.05%462萬 | 12.56%451.6萬 | 33.83%1,717.2萬 | 16.98%448.4萬 | 29.99%447.8萬 | 45.76%419.8萬 | 50.09%401.2萬 |
信貸損失準備金 | 3.56%-2.12億 | 16.34%-5,762.6萬 | -6.71%-5,434.9萬 | -2.38%-5,380.2萬 | 2.61%-4,642.3萬 | -18.86%-2.2億 | -13.32%-6,888.5萬 | -5.95%-5,093萬 | -15.75%-5,255.1萬 | -54.48%-4,766.8萬 |
非利息費用 | 1.88%2.48億 | -0.23%6,464.6萬 | 0.59%6,246.8萬 | 5.69%6,013.6萬 | 1.90%6,044.8萬 | 9.25%2.43億 | 17.51%6,479.6萬 | 6.77%6,210.4萬 | 5.13%5,689.6萬 | 7.66%5,932.3萬 |
設備佔用費 | 3.17%2,582.3萬 | 7.66%674.8萬 | 3.74%655.1萬 | -0.15%614.9萬 | 1.38%637.5萬 | 5.12%2,502.9萬 | 4.52%626.8萬 | 7.99%631.5萬 | 0.03%615.8萬 | 8.26%628.8萬 |
銷售和管理費用 | 1.74%2.22億 | -1.08%5,789.8萬 | 0.23%5,591.7萬 | 6.40%5,398.7萬 | 1.96%5,407.3萬 | 9.75%2.18億 | 19.09%5,852.8萬 | 6.64%5,578.9萬 | 5.78%5,073.8萬 | 7.59%5,303.5萬 |
-管理費用 | 0.27%2.03億 | -1.73%5,312.1萬 | -1.69%5,083.9萬 | 4.81%4,915.1萬 | 0.21%4,975.8萬 | 10.35%2.02億 | 20.37%5,405.4萬 | 6.90%5,171.2萬 | 6.92%4,689.4萬 | 7.48%4,965.6萬 |
-銷售費用 | 20.49%1,900.6萬 | 6.77%477.7萬 | 24.55%507.8萬 | 25.81%483.6萬 | 27.70%431.5萬 | 2.58%1,577.4萬 | 5.54%447.4萬 | 3.48%407.7萬 | -6.43%384.4萬 | 9.32%337.9萬 |
來自聯營公司及其他參與權益的收入(虧損) | ||||||||||
特殊收入(費用) | ||||||||||
其他非經營收入(費用) | ||||||||||
除稅前利潤 | 160.19%5,407.5萬 | 233.81%1,275.5萬 | -6.72%1,016.5萬 | 43.63%1,122.2萬 | 71.76%1,993.3萬 | -68.18%2,078.3萬 | -873.70%-953.2萬 | -18.40%1,089.7萬 | -50.51%781.3萬 | -66.79%1,160.5萬 |
所得稅 | 166.28%1,284.8萬 | 245.10%284.1萬 | 20.46%250.2萬 | 55.14%277.7萬 | 62.14%472.8萬 | -65.77%482.5萬 | -68.94%-195.8萬 | -36.79%207.7萬 | -52.94%179萬 | -64.29%291.6萬 |
除稅後的權益收益 | ||||||||||
除稅後利潤 | 158.35%4,122.7萬 | 230.90%991.4萬 | -13.12%766.3萬 | 40.21%844.5萬 | 74.99%1,520.5萬 | -68.85%1,595.8萬 | -416.77%-757.4萬 | -12.40%882萬 | -49.73%602.3萬 | -67.56%868.9萬 |
持續經營利潤 | 158.35%4,122.7萬 | 230.90%991.4萬 | -13.12%766.3萬 | 40.21%844.5萬 | 74.99%1,520.5萬 | -68.85%1,595.8萬 | -416.77%-757.4萬 | -12.40%882萬 | -49.73%602.3萬 | -67.56%868.9萬 |
歸屬於少數股東的淨利潤 | ||||||||||
歸屬於母公司的淨利潤 | 158.35%4,122.7萬 | 230.90%991.4萬 | -13.12%766.3萬 | 40.21%844.5萬 | 74.99%1,520.5萬 | -68.85%1,595.8萬 | -416.77%-757.4萬 | -12.40%882萬 | -49.73%602.3萬 | -67.56%868.9萬 |
優先股派息 | ||||||||||
其他優先股派息 | ||||||||||
歸屬於普通股股東的淨利潤 | 158.35%4,122.7萬 | 230.90%991.4萬 | -13.12%766.3萬 | 40.21%844.5萬 | 74.99%1,520.5萬 | -68.85%1,595.8萬 | -416.77%-757.4萬 | -12.40%882萬 | -49.73%602.3萬 | -67.56%868.9萬 |
基本每股收益 | 151.76%4.28 | 227.50%1.02 | -15.96%0.79 | 37.50%0.88 | 70.97%1.59 | -69.15%1.7 | -407.69%-0.8 | -13.76%0.94 | -50.39%0.64 | -66.90%0.93 |
稀釋每股收益 | 149.40%4.14 | 222.50%0.98 | -16.48%0.76 | 36.51%0.86 | 73.33%1.56 | -68.68%1.66 | -420.00%-0.8 | -14.15%0.91 | -49.19%0.63 | -66.29%0.9 |
每股派息 | 0.00%1.2 | 0.00%0.3 | 0.00%0.3 | 0.00%0.3 | 0.00%0.3 | 0.00%1.2 | 0.00%0.3 | 0.00%0.3 | 0.00%0.3 | 0.00%0.3 |
貨幣單位 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
會計準則 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
審計意見 | 無保留意見 | -- | -- | -- | -- | 無保留意見 | -- | -- | -- | -- |